OneMedNet Corp. (ONMD) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
OneMedNet Corp. stock (ONMD) is currently trading at $0.87. OneMedNet Corp. PS ratio (Price-to-Sales) is 78.33. WallStSmart rates ONMD as Sell.
- ONMD PE ratio analysis and historical PE chart
- ONMD PS ratio (Price-to-Sales) history and trend
- ONMD intrinsic value — DCF, Graham Number, EPV models
- ONMD stock price prediction 2025 2026 2027 2028 2029 2030
- ONMD fair value vs current price
- ONMD insider transactions and insider buying
- Is ONMD undervalued or overvalued?
- OneMedNet Corp. financial analysis — revenue, earnings, cash flow
- ONMD Piotroski F-Score and Altman Z-Score
- ONMD analyst price target and Smart Rating
OneMedNet Corp.
📊 No data available
Try selecting a different time range
Smart Analysis
OneMedNet Corp. (ONMD) · 5 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in revenue growth. Concerns around market cap and operating margin. Significant fundamental concerns warrant caution or avoidance.
OneMedNet Corp. (ONMD) Key Strengths (1)
Strong revenue growth at 24.60% annually
OneMedNet Corp. (ONMD) Areas to Watch (4)
Losing money on operations
Very expensive at 78.3x annual revenue
Very low institutional interest at 11.67%
Micro-cap company with very limited liquidity and high volatility
Supporting Valuation Data
OneMedNet Corp. (ONMD) Detailed Analysis Report
Overall Assessment
This company scores 14/100 in our Smart Analysis, earning a F grade. Out of 5 metrics analyzed, 1 register as strengths (avg 8.0/10) while 4 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Revenue Growth. Growth metrics are encouraging with Revenue Growth at 24.60%.
The Bear Case
The primary concerns are Operating Margin, Price/Sales, Institutional Own.. Some valuation metrics including Price/Sales (78.33) suggest expensive pricing. Profitability pressure is visible in Operating Margin at -1263.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Operating Margin at -1263.00% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 24.60% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Operating Margin and Price/Sales are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ONMD Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ONMD's Price-to-Sales ratio of 78.33x trades at a deep discount to its historical average of 259.61x (38th percentile). The current valuation is 87% below its historical high of 623.92x set in Sep 2021, and 207% above its historical low of 25.5x in Jan 2024. Over the past 12 months, the PS ratio has expanded from ~44.4x, reflecting growing market expectations outpacing revenue growth.
Compare ONMD with Competitors
Top HEALTH INFORMATION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for OneMedNet Corp. (ONMD) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
OneMedNet Corp. is a strong growth company balancing expansion with improving profitability. Revenue reached 494,000 with 25% growth year-over-year. The company is currently unprofitable, posting a 0.0% profit margin.
Key Findings
Spending 65% of revenue (323,000) on R&D, reinforcing its commitment to innovation and future growth.
Free cash flow is -2M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can OneMedNet Corp. maintain 25%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact OneMedNet Corp..
Bottom Line
OneMedNet Corp. offers an attractive blend of growth (25% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About OneMedNet Corp.(ONMD)
NASDAQ
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
OneMedNet Corporation develops technology that focuses on accessing and sharing health data. The company is headquartered in Eden Prairie, Minnesota with a development office in Vancouver, Canada.